Vascular endothelial growth factor (VEGF) expression in noise-induced hearing loss

Noise-induced hearing loss has been associated with alterations in cochlear blood flow. Our study analyzed the expression of Vascular Endothelial Growth Factor (VEGF) and its functional receptors, Flt-1 and Flk-1, in the cochlear structures of noise-exposed and unexposed guinea pigs. VEGF is a prototypical angiogenic agent, with multiple functions on vascular biology, ranging from vascular permeability to endothelial cell migration, proliferation, differentiation, and survival. Acoustic trauma was induced by a continuous pure tone of 6 kHz, at 120 dB SPL for 30 min. Auditory function was evaluated by electrocochleographic recordings at 2-20 kHz for 7 days. Noise-induced cochlear morphological changes were studied by immunohistochemistry and scanning electron microscopy. The expression of VEGF and its receptors was examined by immunohistochemistry and western blotting analysis. The hearing threshold shift reached a level of 60 dB SPL on day 1 after trauma and underwent a partial recovery over time, reaching a value of about 20 dB SPL on day 7. Outer hair cell loss was more prominent in the area located 14-16 mm from the apex. Increased cochlear VEGF expression was observed in noise-exposed animals, in particular at the level of stria vascularis, spiral ligament, and spiral ganglion cells. No changes were observed in the expression of VEGF-receptors. Our data suggest a role for VEGF in the regulation of the vascular network in the inner ear after acoustic trauma and during auditory recovery, with potentially important clinical and therapeutic implications.

[1]  I. Pyykkö,et al.  Vibration induced hearing loss in guinea pig cochlea: expression of TNF-α and VEGF , 2005, Hearing Research.

[2]  E. Scarano,et al.  Protective Effects of α-Tocopherol Against Gentamicin-induced Oto-vestibulo Toxicity: An Experimental Study , 2003, Acta oto-laryngologica.

[3]  B. Bontempi,et al.  Systemic Morphine-Induced Fos Protein in the Rat Striatum and Nucleus Accumbens Is Regulated by μ Opioid Receptors in the Substantia Nigra and Ventral Tegmental Area , 1997, The Journal of Neuroscience.

[4]  J. Bm,et al.  Electrophysiological and morphological correlates in the guinea pig cochlea after exposure to 'impulsive' noise. , 1980 .

[5]  E. Voest,et al.  Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. , 1996, The Journal of clinical investigation.

[6]  M. Barbara,et al.  Laser Doppler Measurement of Cochlear Blood Flow Changes During Conditioning Noise Exposure , 2001, Acta oto-laryngologica.

[7]  James S. Wright,et al.  Early Elevation of Cochlear Reactive Oxygen Species following Noise Exposure , 1999, Audiology and Neurotology.

[8]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[9]  J. Isner,et al.  Reversal of experimental diabetic neuropathy by VEGF gene transfer. , 2001, The Journal of clinical investigation.

[10]  Jing Wang,et al.  Riluzole rescues cochlear sensory cells from acoustic trauma in the guinea-pig , 2002, Neuroscience.

[11]  H. Dengerink,et al.  The effects of noise on histological measures of the cochlear vasculature and red blood cells: A review , 1987, Hearing Research.

[12]  J. Isner,et al.  Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. , 2001, Archives of neurology.

[13]  A. Fetoni,et al.  Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage 1 1 Preliminary results were presented at the 39th Workshop on Inner Ear Biology, Liège, 7–11 Sempember 2002. , 2003, Hearing Research.

[14]  J. Isner,et al.  VEGF gene transfer for diabetic neuropathy. , 2001, Human gene therapy.

[15]  G. Lundborg,et al.  Vascular Endothelial Growth Factor Has Neurotrophic Activity and Stimulates Axonal Outgrowth, Enhancing Cell Survival and Schwann Cell Proliferation in the Peripheral Nervous System , 1999, The Journal of Neuroscience.

[16]  Gaetano Paludetti,et al.  Age-dependent modifications of expression level of VEGF and its receptors in the inner ear , 2004, Experimental Gerontology.

[17]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Y. Nakai,et al.  Strial circulation impairment due to acoustic trauma. , 1991, Acta oto-laryngologica.

[19]  J. Folkman,et al.  Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen , 1995 .

[20]  Till Acker,et al.  Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration , 2001, Nature Genetics.

[21]  W. Arnold,et al.  Noise-induced cochlear hypoxia is intensity dependent, correlates with hearing loss and precedes reduction of cochlear blood flow. , 1996, Audiology & neuro-otology.

[22]  K. Ohlemiller,et al.  Elevation of Reactive Oxygen Species following Ischemia-Reperfusion in Mouse Cochlea Observed in vivo , 1999, Audiology and Neurotology.

[23]  N. Ferrara,et al.  Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes , 1997, The Journal of Biological Chemistry.

[24]  M. Seidman,et al.  Cochlear vascular changes in response to loud noise. , 1995, The American journal of otology.

[25]  F. Scheibe,et al.  Intensity-related changes in cochlear blood flow in the guinea pig during and following acoustic exposure , 2004, European Archives of Oto-Rhino-Laryngology.

[26]  J. Caro,et al.  Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[27]  F. de Ribaupierre,et al.  A Peptide Inhibitor of C-jun N-terminal Kinase Protects against Both Aminoglycoside and Acoustic Trauma-induced Auditory Hair Cell Death and Hearing Loss , 2022 .

[28]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[29]  P. Carmeliet,et al.  Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. , 2002, Seminars in cell & developmental biology.

[30]  Pasqualina M. Picciotti,et al.  Expression of vascular endothelial growth factor and its receptors in the cochlea of various experimental animals , 2005, Acta oto-laryngologica.

[31]  M. Liberman,et al.  Lateral Wall Histopathology and Endocochlear Potential in the Noise-Damaged Mouse Cochlea , 2003, Journal of the Association for Research in Otolaryngology.

[32]  J. Alroy,et al.  Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy , 2000, Nature Medicine.

[33]  W. Bloch,et al.  Immunohistochemical detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR/Flk-1 in the cochlea of guinea pigs , 2001, Hearing Research.